Quest Diagnostics to Form Precision Oncology Center of Excellence Through Acquisition of Two Texas Laboratory Businesses to Serve Oncologists Nationwide

Quest Diagnostics (NYSE: DGX)  announced that it has signed definitive agreements to acquire two laboratory businesses in Lewisville, Texas, with the aim to establish... Read More
June 16, 2017

California Life Sciences Association Applauds Gov. Brown & Legislature on Budget Agreement that Invests $10M in Precision Medicine

California Life Sciences Association (CLSA), the premier public policy advocacy and business leadership trade association representing California’s life sciences industry, today issued the following... Read More
June 16, 2017

Covance Opens State-of-the-Art Laboratory for Companion Diagnostics

LabCorp® a leading global life sciences company, announced today that its Covance Drug Development (Covance) business will extend its capabilities in precision medicine by... Read More
May 26, 2017

Seattle Children’s Brings First-of-its-kind Precision Medicine Clinical Trial to Inflammatory Bowel Disease, Bone Marrow Transplant Patients

In an effort to find new strategies to personalize treatment for pediatric patients, Seattle Children’s has opened the first clinical trial applying next-generation T-cell... Read More
May 26, 2017

Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder

Owlstone Medical, a diagnostics company developing a breathalyzer for disease, announced today the appointment of Professor Sir Bruce Ponder FRCP FMedSci FRS to its... Read More
May 26, 2017

University of Huddersfield to invest in pharmacy research expansion

Pharmacy experts at the University of Huddersfield have held a special brainstorming session that will lead to an action plan designed to boost research... Read More
May 17, 2017

OncoDNA Signs Agreement with its Middle-East Distributor CryoGene for the MOCS (Multi-centric OncoDNA Combined Study) Research

This project is the first prospective regional molecular profiling program that combines liquid and solid analyses aspiring to improve the lives of patients with... Read More
May 17, 2017

Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Disorders in Newborns

The Rady Children’s Institute for Genomic Medicine (RCIGM) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) have announced a strategic partnership to accelerate the diagnosis of... Read More
May 17, 2017

Phase Genomics Announces the Commercial Availability of ProxiMeta™ Hi-C

Seattle-based Phase Genomics announced today the general availability of its new ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta enables researchers to obtain complete, distinct genomes... Read More
May 17, 2017

Penn Medicine Researchers Identify Biomarkers That May Predict Cognitive Impairment in New Parkinson’s Disease Patients

New biomarkers identified by a research team in the Perelman School of Medicine at the University of Pennsylvania could help predict which Parkinson’s disease... Read More
May 17, 2017

Agilent Technologies Announces Expanded Use for PD-L1 IHC 28-8 pharmDx Diagnostic in Europe

Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent´s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the... Read More
April 29, 2017

Tempus Announces BRCA Focused Initiative in Partnership with Penn’s Basser Center for BRCA

Tempus, a technology company focused on helping doctors personalize cancer treatment by collecting, sorting and analyzing clinical and molecular data, has announced a new... Read More
April 29, 2017

ChromaCode Raises $12 Million in Series B Funding for Commercial Launch and Appoints Alex Dickinson as Executive Chair

ChromaCode, Inc., a molecular diagnostics company, announced it has raised $12 million in Series B funding. This latest round is led by New Enterprise... Read More
April 29, 2017

WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine

Weill Cornell Medicine has announced a gift made by WorldQuant, LLC (“WorldQuant”) and Igor Tulchinsky that will further realize the promise of precision medicine.... Read More
April 24, 2017

Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics, the Irish data insights and solutions company enabling better patient testing globally, has announced 30 new jobs as it continues to lead the... Read More
April 24, 2017

Top three global diagnostics company takes exclusive rights to several of Avacta’s Affimer reagents

Avacta Group plc (AIM: AVCT) (Avacta), the developer of Affimer® biotherapeutics and research reagents, is pleased to report that an evaluation of the Affimer... Read More